Dizal (jiangsu) Pharmaceutical Co., Ltd.

This study tests a new combination of two drugs, DZD6008 and sunvozertinib, in adults with advanced non-small cell lung cancer that has certain EGFR mutations. The goal is to see if the combination is safe and can shrink tumors. About 200 people will take part in this early-phase…

This study tests a new drug combination (DZD8586 plus other medicines) in 66 adults with chronic lymphocytic leukemia or small lymphocytic lymphoma who are newly diagnosed or have not yet been treated. The goal is to see if the combination is safe and can keep the cancer from gro…

This study tests a new drug, DZD8586, against standard treatments in 250 adults with chronic lymphocytic leukemia or small lymphocytic lymphoma that has come back or stopped responding to prior therapy. The main goal is to see if DZD8586 can delay cancer growth longer than the do…

This study tests an experimental drug called sunvozertinib against a placebo in people with a specific type of lung cancer (non-small cell) that has certain gene changes (EGFR exon20 insertion or PACC mutations). Participants must have had their tumor completely removed by surger…